These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Waggoner SE, Anderson SM, Luce MC, Takahashi H, Boyd J. Gynecol Oncol; 1996 Mar; 60(3):339-44. PubMed ID: 8774636 [Abstract] [Full Text] [Related]
12. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. Melnick S, Cole P, Anderson D, Herbst A. N Engl J Med; 1987 Feb 26; 316(9):514-6. PubMed ID: 3807995 [Abstract] [Full Text] [Related]
14. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain. Lin LM, Sciubba DM, Gallia GL, Sosnowski J, Weingart JD. Gynecol Oncol; 2007 Apr 26; 105(1):273-6. PubMed ID: 17292458 [Abstract] [Full Text] [Related]
15. Diethylstilbestrol in pregnancy: an update. Kinch RA. Can Med Assoc J; 1982 Nov 01; 127(9):812-3. PubMed ID: 7139494 [Abstract] [Full Text] [Related]
19. In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium. Larson PS, Ungarelli RA, de Las Morenas A, Cupples LA, Rowlings K, Palmer JR, Rosenberg CL. Cancer; 2006 Nov 01; 107(9):2122-6. PubMed ID: 16998936 [Abstract] [Full Text] [Related]